Relay Therapeutics (RLAY) PT Raised to $19 at Citizens -Triplet Update a 'Strong Positive'
Citizens analyst Silvan Turkcan raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $19.00 (from $17.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
